Yat Sun Or - Net Worth and Insider Trading
Yat Sun Or Net Worth
The estimated net worth of Yat Sun Or is at least $4 Million dollars as of 2024-11-05. Yat Sun Or is the Sr. VP, R&D & CSO of Enanta Pharmaceuticals Inc and owns about 370,695 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $4 Million. Details can be seen in Yat Sun Or's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yat Sun Or has not made any transactions after 2023-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yat Sun Or
Yat Sun Or Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yat Sun Or owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Yat Sun Or’s form 4 insider trades.
Insider Ownership Summary of Yat Sun Or
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | Chief Scientific Officer |
Yat Sun Or Latest Holdings Summary
Yat Sun Or currently owns a total of 1 stock. Yat Sun Or owns 370,695 shares of Enanta Pharmaceuticals Inc (ENTA) as of December 5, 2023, with a value of $4 Million.
Latest Holdings of Yat Sun Or
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | 370,695 | 11.26 | 4,174,026 |
Holding Weightings of Yat Sun Or
Yat Sun Or Form 4 Trading Tracker
According to the SEC Form 4 filings, Yat Sun Or has made a total of 2 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 2,412 shares on December 5, 2023, which brought Yat Sun Or around $23,228.
Insider Trading History of Yat Sun Or
- 1
Yat Sun Or Trading Performance
Yat Sun Or Ownership Network
Ownership Network List of Yat Sun Or
Ownership Network Relation of Yat Sun Or
Yat Sun Or Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Yat Sun Or is the Chief Scientific Officer of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Sr. VP & Business Dev. Brendan Luu .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Yat Sun Or made 1 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 2,412. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 15,295 shares made by Terry Vance .
In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Yat Sun Or Mailing Address
Above is the net worth, insider trading, and ownership report for Yat Sun Or. You might contact Yat Sun Or via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
